OR WAIT 15 SECS
Greenphire, based in suburban Philadelphia, and San Francisco startup Mytrus Inc. have developed web-based solutions to streamline the tasks of recruiting, retaining, and efficiently administering clinical trials. Greenphire’s ClinCard System, a web-based patient payment, management, and communication platform, compliments the functionality offered by Mytrus and its methods for allowing patients to participate in clinical research studies from their homes.
Greenphire and Mytrus hope to empower patients to play a larger and more critical role in pharmaceutical development. Mytrus allows patients to use web technology to provide their own study data over the Internet and then be immediately compensated directly to a Greenphire ClinCard debit card the patient carries around in their wallet.
Greenphire’s patent-pending ClinCard technology offers a fully configurable, web-based patient payment, management, and communication engine, enabling sponsor and site administrators to deliver study-specific messaging programs executed by text, email, and voice messages while delivering patient stipends, managing patient travel arrangements, and providing travel reimbursements in a controlled and automated real-time environment. The ClinCard’s functionality is in compliance with industry regulation and implemented according to the requirements of each specific study protocol. The ClinCard System has been proven to drive increased site and patient satisfaction, reduced site and sponsor administration, increased patient retention, increased protocol compliance, and reduced regulatory risk for the sponsor.
Mytrus’model uses web-based tools for recruiting and managing patients from a single remote site in San Francisco. Mytrus studies feature Greenphire’s ClinCard technology to deliver real-time stipend and reimbursement payments to their study participants. Patients receive a ClinCard immediately upon study enrollment and then receive milestone payments as they progress through a study.